HomePUNJABCHEM › Filing
🔔 Get instant alerts when PUNJABCHEM files quarterly results on BSE Start free trial →

Outcome of Board Meeting

Filed: 31 Jul 2026, 13:08 IST Exchange: NSE Category: Financial Results — Audited Results
Q1FY27 results (unaudited): Standalone: Revenue 3.5bn +9% y-y (3.2bn) PAT 0.22bn +10% y-y (0.20bn) Consolidated: Revenue 3.5bn +9% y-y (3.2bn) PAT 0.22bn +7% y-y (0.21bn) FY26 results (audited): Standalone: Revenue 10.3bn +2% y-y (10.0bn) EBITDA 0.95bn +6% y-y (0.90bn) EBITDA margin 9.3% (9.0%) +30 bps y-y PAT 0.61bn +7% y-y (0.57bn) Consolidated: Revenue 10.5bn +2% y-y (10.3bn) EBITDA 0.95bn +6% y-y (0.90bn) EBITDA margin 9.1% (8.8%) +30 bps y-y PAT 0.64bn +7% y-y (0.60bn) Dividend: Rs 3.00/share (recommended for FY26, subject to AGM approval) Commentary: Exceptional item of Rs 0.021bn in FY26 relates to impact of New Labour Codes.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 PUNJABCHEM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add PUNJABCHEM to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Punjab Chemicals & Crop Protection Limited

Important. The summary above is generated automatically from Punjab Chemicals & Crop Protection Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.